Guangzhou Huiyuan Pharmaceutical Technology

Guangzhou Huiyuan Pharmaceutical Technology Co., Ltd. is a pharmaceutical research and development company based in Guangzhou, China, and a subsidiary of the Da Shen Lin Pharmaceutical Group. Established in 2019, the company focuses on the development of generic drugs, improved formulations (new dosage forms), and health foods. It operates as a Marketing Authorization Holder (MAH) and provides comprehensive technical services, including formulation R&D, clinical research support, and project consulting. The company leverages a strong technical partnership with experts from Sun Yat-sen University to advance its pipeline of generic and improved drug products. Its portfolio includes treatments for oncology, dermatology, and cardiovascular conditions, with several products currently in the regulatory approval process.